Bank of China International: "Buy" rating for GREENTOWN SER (02869) with target price lowered to 4.29 Hong Kong dollars.
Bank of China International lowers Greentown Service's 2024 revenue forecast by 3.7% to 18.6 billion yuan, which means a year-on-year growth of 7.1%.
The report released by CINDA International stated that considering the efficiency improvement of GREENTOWN SER (02869), its strong competitiveness in the residential sector, cooperation with large state-owned enterprises, and stable cash flow, the company is given a "buy" rating. However, the target price has been reduced from 4.36 Hong Kong dollars to 4.29 Hong Kong dollars.
The bank predicts that the value of new contracts for GREENTOWN SER last year will be lower than the original target. The group will continue to adjust its strategy, focusing on core, sustainable, and profitable Value-Added Services (VAS) business. Therefore, the bank has lowered the group's 2024 revenue forecast by 3.7% to 18.6 billion RMB, implying a year-on-year growth of 7.1%.
CINDA International stated that GREENTOWN SER's efficiency continues to improve, with the group's gross profit margin expected to increase by 0.3 percentage points to 17.1% in 2024. Sales and administrative expenses as a percentage of revenue will decrease by 0.5 percentage points. The bank estimates that the group's core net profit will increase by 9.6% year-on-year to 835 million RMB.
Related Articles

HK Stock Market Move | DOBOT(02432) rose more than 6%, and the company's two shareholders have voluntarily promised not to reduce their holdings for one year.

Shenwan Hongyuan Group: Upgrades BIDU-SW (09888) to "buy" rating with a target price of 172.54 Hong Kong dollars.

HK Stock Market Move | BIOCYTOGEN-B (02315) increases by over 6% again, reaching a new high. The company has officially entered the Hong Kong Stock Connect. Institutions believe that the prospects for Biocytogen are broad.
HK Stock Market Move | DOBOT(02432) rose more than 6%, and the company's two shareholders have voluntarily promised not to reduce their holdings for one year.

Shenwan Hongyuan Group: Upgrades BIDU-SW (09888) to "buy" rating with a target price of 172.54 Hong Kong dollars.

HK Stock Market Move | BIOCYTOGEN-B (02315) increases by over 6% again, reaching a new high. The company has officially entered the Hong Kong Stock Connect. Institutions believe that the prospects for Biocytogen are broad.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


